AJOG MFM/LinkedIn
Dec 26, 2025, 13:09
Postpartum Readmission Rates Linked to Antihypertensive Choice – AJOG MFM
American Journal of Obstetrics and Gynecology MFM – AJOG MFM shared a post on LinkedIn:
“In a retrospective cohort of individuals with hypertensive disorders of pregnancy, discharge with labetalol rather than nifedipine was independently associated with increased risk of postpartum hospital readmission (9.2% vs 3.9%, P<.001).
Read the full text here.”
Title: Postpartum health-care utilization and blood pressure control by antihypertensive agent in hypertensive disorders of pregnancy
Authors: Carrie Bennett, Lara Lemon, Kripa Venkatakrishnan, Sanjana Ghosh, Hyagriv Simhan, Alisse Hauspurg
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Aug 31, 2026, 17:24Riikka Leppänen: Happy to Attend the Nordic Fertility Society Congress 2026
-
Aug 31, 2026, 17:18Brian A. Levine: The Question of Whether to Try Again is One of The Hardest in Medicine
-
Aug 31, 2026, 17:13Aumatma Simmons: Trying to Conceive Can Feel Like a Full-Time Job…
-
Aug 31, 2026, 17:11Nalanda Jayadev: What if “Knowing Early” Could “Change” a Child’s Future?
-
Aug 31, 2026, 17:04Oluyemisi Famuyiwa: Your Fertility Story Should Begin with Knowledge, Not a Crisis
-
Aug 31, 2026, 17:01Vasileios Sarafis: The S.A.F.A.R.I. Protocol – 6 Domains, 1 Structured Plan
-
Aug 31, 2026, 16:54Amitha Nanjundaiah: Should We Aim for Better Oocyte Quality or Greater Oocyte Numbers?
-
Aug 31, 2026, 16:51Sahana C: In Fertility, the Messiness of Clinical Analytics Is Real
-
Aug 31, 2026, 16:46Elham Mohammadzadeh: Attending Excellent Scientific Sessions at NFS 2026